WHOOP Broadens WHOOP Advanced Labs Offering, Announcing a Women’s Health Specialized Blood Biomarker Panel

WHOOP Broadens WHOOP Advanced Labs Offering, Announcing a Women's Health Specialized Blood Biomarker Panel Business Wire

Article content

WHOOP deepens investment in women’s physiology with clinically meaningful lab testing, predictive symptom modeling, and new Menstrual Cycle White Paper

Article content

BOSTON — WHOOP, the human performance company, today unveiled multiple initiatives and new clinically-backed features, including the coming launch of the company’s Women’s Health Specialized Blood Biomarker Panel. Building on the WHOOP Advanced Labs Baseline Panel launched last year, the Women’s Health Specialized Blood Biomarker Panel adds 11 clinically backed, female-specific blood biomarkers that expand insight into areas that are frequently under-measured or misinterpreted in traditional women’s health testing. WHOOP has also announced a new Hormonal Symptom Insights and Predictions update, along with a comprehensive Menstrual Cycle White Paper detailing the science behind its cycle modeling.

Article content

Article content

Article content

These initiatives reflect the company’s commitment to advancing women’s health in an area that has historically been under-researched and underrepresented in data, clinical standards, and performance science. Women represent a growing share of new WHOOP members, with 150% year-over-year growth, signaling increasing demand for health insights that account for hormonal dynamics, training response, and long-term health outcomes. Women also engage with WHOOP AI approximately 30% more than male members, reflecting strong demand for intelligent, personalized women’s health support.

Article content

Article content

“Unlike solutions that focus on isolated conditions or single life stages, WHOOP delivers a connected health experience informed by one of the world’s largest datasets on women’s physiology,” said Alex Vannoni, Head of Healthcare Product at WHOOP. “We’re not just helping women track their cycles. We’re helping them understand how their physiology evolves over time – and giving them tools to act on it.”

Article content

WHOOP Advanced Labs: Women’s Health Specialized Panel

Article content

The Advanced Labs baseline and new Women’s Health Specialized Panel create a progressive, female-first testing pathway that supports women across all life stages.

Article content

The new panel, launching next month, includes critical biomarkers that dive deeper into cycle regulation and hormonal transitions, including perimenopause, thyroid function, nutrient sufficiency, and bone–metabolic resilience. The biomarkers tested are: Anti-Müllerian Hormone (AMH), Progesterone, Prolactin and Thyroid Peroxidase Antibodies (TPOAb), Free T4, Free T3, Leptin, Vitamin B12 (Cobalamin), Folate, Magnesium and Phosphate (as Phosphorus).

Article content

By layering lab data on top of continuous wearable metrics and AI-modelling, WHOOP enables members to see how biomarkers correlate with recovery trends, strain tolerance, sleep efficiency, and stress patterns over time – turning static lab results into dynamic insight.

Article content

Members will be able to purchase the Women’s Health Specialized Panel via the WHOOP app.

Article content

Hormonal Symptom Insights and Predictions

Article content

WHOOP is also expanding its Menstrual Cycle Insights and Pregnancy Insights offering, with a new update – Hormonal Symptom Insights and Predictions. Within the WHOOP app, menstruating members will now receive a personalized model of their cycle that adapts over time, based on their unique physiological data and historical patterns.

Article content

Article content

Within the WHOOP app, members will now have access to key data about their cycle that allows them to accurately adjust their daily routines, fitness regimes, and recovery practices and anticipate potential symptoms rather than simply recording them. This includes access to:

Article content

Article content

As part of the latest Cycle Insights updates, the feature now integrates with WHOOP Advanced Labs. This integration enables WHOOP to deliver personalized biomarker ranges – categorized as ‘optimal,’ ‘sufficient,’ or ‘out of range’ – based on where a member is in their cycle. When a member completes a blood draw, WHOOP automatically applies the appropriate reference range aligned to their recorded cycle phase, ensuring results are interpreted through the lens of their physiology. It’s another example of how women’s unique biology is embedded into every WHOOP product and feature.

Article content

Menstrual Cycle White Paper

Article content

WHOOP has also published a comprehensive Menstrual Cycle White Paper outlining the research, methodology, and validation behind its modeling approach. The white paper proves how continuous physiological monitoring improves prediction accuracy over time, how the system accounts for variable cycles, perimenopause, and hormonal birth control, and how prediction windows dynamically widen or narrow based on variability.

Article content

By bringing continuous, longitudinal visibility to cycle patterns, WHOOP aims to increase health literacy and close a long-standing data gap in women’s health.

Article content

“What makes this powerful isn’t any single data point – it’s how the system comes together,” said Emily Capodillupo, Senior Vice President of Research, Algorithms, and Data at WHOOP. “Women don’t experience their physiology in silos. Hormones influence sleep, sleep affects recovery, and recovery shapes training response. By modeling these interactions over time – across continuous biometrics, lab data, and behavior – we can deliver guidance that reflects the full system, not just a snapshot.”

Article content

With the support of the WHOOP Medical Advisory Board, including Dr. Robin Berzin and Dr. Hazel Wallace, and in tandem with their recent collaboration with Clue, a leader in menstrual and reproductive health, WHOOP will continue to drive innovation in women’s health and deliver on the company’s goal of adding one billion healthy years to the planet.